Age (years) [median (range)]	55 (21-73)
Gender (male/female) (n)	15/12
Diagnosis [n(%)]
Acute myeloid leukemia	12 (44.5)
Acute lymphoblastic leukemia	10 (37)
Non-Hodgkin lymphoma	3 (11.1)
Multiple myeloma	1 (3.7)
Primary myelofibrosis	1 (3.7)
Pre-transplant Disease Status [n(%)]
CR	20 (74.1)
PR	3 (11.1)
PD	3 (11.1)
SD	1 (3.7)
Donor Type [n(%)]
MRD	15 (55.6)
MUD	1 (3.7)
MMRD	1 (3.7)
MMUD	5 (18.5)
Haploidentical	5 (18.5)
Neutrophil Engraftment (days) [median (range)]	15 (10-32)
Platelet Engraftment (days) [median (range)]	16 (9-146)
Previous Cytomegalovirus Reactivation [n(%)]	23 (85.2)
Previous Acute GvHD [n(%)]	13 (48.1)
Post-transplant Day [median (range)]	55 (21-134)
Grade [median (range)]	2 (1-4)
Previous Chronic GvHD [n(%)]	6 (22.2)
Post-transplant Day [median (range)]	188 (126-586)
Stage
Limited [n(%)]	4 (66.7)
Extended [n(%)]	2 (33.3)